{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:15:49Z","timestamp":1790648149432,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1213\/ane.0000000000000640","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T08:44:43Z","timestamp":1424767483000},"page":"1385-1393","source":"Crossref","is-referenced-by-count":19,"title":["The Effects of Levetiracetam, Sumatriptan, and Caffeine in a Rat Model of Trigeminal Pain"],"prefix":"10.1213","volume":"120","author":[{"given":"Maja A.","family":"Tomi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uro\u0161 B.","family":"Pecikoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Micov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017eidar V.","family":"Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radica M.","family":"Stepanovi\u0107-Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-30-20210902","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpain.2010.07.006","article-title":"Combination drug therapy for chronic pain: a call for more clinical studies.","volume":"12","author":"Mao","year":"2011","journal-title":"J Pain"},{"key":"R5-30-20210902","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1476-5381.2010.00877.x","article-title":"The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action.","volume":"161","author":"Micov","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R6-30-20210902","first-page":"953","article-title":"Preemptive levetiracetam decreases postoperative pain in rats.","volume":"29","author":"Sliva","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"R7-30-20210902","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1213\/ANE.0b013e31826c7fc2","article-title":"The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.","volume":"115","author":"Stepanovic-Petrovic","year":"2012","journal-title":"Anesth Analg"},{"key":"R8-30-20210902","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/ALN.0000435833.33515.ba","article-title":"Antihyperalgesicantinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents.","volume":"120","author":"Stepanovic-Petrovic","year":"2014","journal-title":"Anesthesiology"},{"key":"R9-30-20210902","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(03)01933-2","article-title":"Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.","volume":"473","author":"Ardid","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"R10-30-20210902","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1399-6576.2007.01578.x","article-title":"Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy.","volume":"52","author":"Ozcan","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-30-20210902","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1468-1331.2009.02585.x","article-title":"Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia.","volume":"16","author":"Jorns","year":"2009","journal-title":"Eur J Neurol"},{"key":"R12-30-20210902","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1526-4610.2010.01743.x","article-title":"An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia.","volume":"50","author":"Mitsikostas","year":"2010","journal-title":"Headache"},{"key":"R13-30-20210902","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","article-title":"Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.","volume":"29","author":"Brighina","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"R14-30-20210902","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1526-4610.2007.00728.x","article-title":"Levetiracetam prophylaxis in pediatric migraine-an open-label study.","volume":"47","author":"Pakalnis","year":"2007","journal-title":"Headache"},{"key":"R15-30-20210902","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/187152411794961086","article-title":"Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam.","volume":"11","author":"Pizza","year":"2011","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"R16-30-20210902","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam.","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R17-30-20210902","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2013.06.003","article-title":"Levetiracetam interacts synergistically with nonsteroidal analgesics and caffeine to produce antihyperalgesia in rats.","volume":"14","author":"Tomic","year":"2013","journal-title":"J Pain"},{"key":"R18-30-20210902","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425255.2013.744394","article-title":"Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.","volume":"9","author":"Tfelt-Hansen","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R19-30-20210902","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1526-4610.2011.02058.x","article-title":"Pharmacological synergy: the next frontier on therapeutic advancement for migraine.","volume":"52","author":"Blumenfeld","year":"2012","journal-title":"Headache"},{"key":"R20-30-20210902","first-page":"CD008541","article-title":"Sumatriptan plus naproxen for acute migraine attacks in adults.","volume":"10","author":"Law","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-30-20210902","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pain.2010.10.011","article-title":"Caffeine and pain.","volume":"152","author":"Sawynok","year":"2011","journal-title":"Pain"},{"key":"R22-30-20210902","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-642-13443-2_11","article-title":"Methylxanthines and pain.","volume":"200","author":"Sawynok","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"R23-30-20210902","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11916-008-0052-z","article-title":"Caffeine and headaches.","volume":"12","author":"Shapiro","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"R24-30-20210902","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2003.12.003","article-title":"The orofacial formalin test.","volume":"28","author":"Raboisson","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"R25-30-20210902","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method.","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"key":"R27-30-20210902","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pain.2004.07.010","article-title":"The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists.","volume":"111","author":"Tomic","year":"2004","journal-title":"Pain"},{"key":"R28-30-20210902","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.pbb.2010.11.007","article-title":"Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia.","volume":"97","author":"Stepanovic-Petrovic","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"R30-30-20210902","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1213\/ANE.0b013e3181cbd8da","article-title":"Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents.","volume":"110","author":"Tomic","year":"2010","journal-title":"Anesth Analg"},{"key":"R32-30-20210902","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1213\/ANE.0b013e31829ed28f","article-title":"Wilcoxon-Mann-Whitney test used for data that are not normally distributed.","volume":"117","author":"Dexter","year":"2013","journal-title":"Anesth Analg"},{"key":"R33-30-20210902","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1213\/ANE.0b013e31827f53d7","article-title":"Statistical grand rounds: a review of analysis and sample size calculation considerations for Wilcoxon tests.","volume":"117","author":"Divine","year":"2013","journal-title":"Anesth Analg"},{"key":"R34-30-20210902","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","article-title":"Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety.","volume":"53","author":"Munro","year":"2007","journal-title":"Neuropharmacology"},{"key":"R35-30-20210902","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0301-0082(93)90044-S","article-title":"Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model.","volume":"41","author":"Porro","year":"1993","journal-title":"Prog Neurobiol"},{"key":"R36-30-20210902","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.lfs.2013.03.023","article-title":"Role of 5-HT1B1D receptors in the reduction of formalin-induced nociception and secondary allodyniahyperalgesia produced by antimigraine drugs in rats.","volume":"92","author":"Godinez-Chaparro","year":"2013","journal-title":"Life Sci"},{"key":"R37-30-20210902","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pain.2008.06.002","article-title":"Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan.","volume":"139","author":"Nikai","year":"2008","journal-title":"Pain"},{"key":"R38-30-20210902","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3959(94)00169-F","article-title":"Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms.","volume":"61","author":"Sawynok","year":"1995","journal-title":"Pain"},{"key":"R39-30-20210902","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00791-1","article-title":"Caffeine antinociception: role of formalin concentration and adenosine A1 and A2 receptors.","volume":"298","author":"Sawynok","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R40-30-20210902","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1016\/S0924-977X(11)70435-7","article-title":"Caffeine antagonizes the antihyperalgesic effect of levetiracetam in a rat model of inflammatory hyperalgesia.","volume":"21","author":"Micov","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"R41-30-20210902","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neulet.2010.02.028","article-title":"Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice.","volume":"473","author":"Sawynok","year":"2010","journal-title":"Neurosci Lett"},{"key":"R42-30-20210902","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0006-8993(02)03568-0","article-title":"Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice.","volume":"956","author":"Borghi","year":"2002","journal-title":"Brain Res"},{"key":"R43-30-20210902","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pain.2007.01.013","article-title":"The antinociceptive effect of 2-chloro-2. -C-methyl-N6-cyclopentyladenosine (2-Me-CCPA), a highly selective adenosine A1 receptor agonist, in the rat.","volume":"131","author":"Maione","year":"2007","journal-title":"Pain"},{"key":"R44-30-20210902","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1016\/S0924-977X(11)70449-7","article-title":"The involvement of adenosine A1 receptors in the antihyperalgesic effect of levetiracetam.","volume":"21","author":"Stepanovic-Petrovic","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"R45-30-20210902","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.20193","article-title":"Activation of 5-HT(1B1D) receptor in the periaqueductal gray inhibits nociception.","volume":"56","author":"Bartsch","year":"2004","journal-title":"Ann Neurol"},{"key":"R46-30-20210902","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pain.2004.05.018","article-title":"Effects of sumatriptan on rat medullary dorsal horn neurons.","volume":"111","author":"Jennings","year":"2004","journal-title":"Pain"},{"key":"R47-30-20210902","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.0306147101","article-title":"Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B1D receptor agonists.","volume":"101","author":"Levy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-30-20210902","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0301-0082(03)00050-9","article-title":"Adenosine in the spinal cord and periphery: release and regulation of pain.","volume":"69","author":"Sawynok","year":"2003","journal-title":"Prog Neurobiol"},{"key":"R49-30-20210902","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-4328(96)00072-1","article-title":"Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception.","volume":"73","author":"Sawynok","year":"1996","journal-title":"Behav Brain Res"},{"key":"R50-30-20210902","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0899-9007(00)00369-5","article-title":"Caffeine and nutrition.","volume":"16","author":"Harland","year":"2000","journal-title":"Nutrition"},{"key":"R51-30-20210902","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/sj.bjp.0704599","article-title":"Neostigmine interactions with non steroidal anti-inflammatory drugs.","volume":"135","author":"Miranda","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R52-30-20210902","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00000542-199910000-00021","article-title":"Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats.","volume":"91","author":"Yoon","year":"1999","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:48Z","timestamp":1786112388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201506000-00030"}},"subtitle":["Interactions in 2-Component Combinations"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000640","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}